Showing 7001-7010 of 10469 results for "".
- Statement from AAD President Henry W. Lim, MD, FAAD, on the Safety of Sunscreenhttps://practicaldermatology.com/news/statement-from-aad-president-henry-w-lim-md-faad-on-the-safety-of-sunscreen/2458179/“The American Academy of Dermatology wants to emphasize that sunscreen remains a safe, effective form of sun protection. As one component of a daily sun-protection strategy, sunscreen is an important tool in the fight against skin cancer, including melanoma, the deadliest form of skin cance
- Consumer Reports: One-Third of Tested Sunscreens Delivered Less Than Half of Labeled SPF Protectionhttps://practicaldermatology.com/news/consumer-reports-one-third-of-tested-sunscreens-delivered-less-than-half-of-labeled-spf-protection/2458180/For the fifth year in a row, Consumer Reports’ testing has shown that some sunscreens failed to provide the level of protection promised on the package. Of the more than 60 lotions,&nb
- SkinCeuticals Study Finds Antioxidants Protect Against Atmospheric Skin Aginghttps://practicaldermatology.com/news/skinceuticals-study-finds-antioxidants-protect-against-atmospheric-skin-aging/2458181/Exposure to ozone pollution zaps our collagen supply, according to new research from SkinCeuticals in partnership with Professor Giuseppe Valacchi from the University of Ferrara, Italy. After exposure to 0.8ppm ozone, collage
- Valeant Dermatology Announces New Senior Leadership Team in Advance of SILIQ Launchhttps://practicaldermatology.com/news/valeant-dermatology-announces-new-senior-leadership-team-in-advance-of-siliq-launch/2458182/Valeant Dermatology announced a new senior leadership team, led by Bill Humphries, executive vice president and group chairman. The team includes Michael McMyne, vice president of sales; Stacey Williams, vice president of marketing; Charles Hahn,
- CVS Pharmacy's New Long Live Skin Campaign Aims to Increase Awareness of Skin Healthhttps://practicaldermatology.com/news/cvs-pharmacys-new-long-live-skin-campaign-aims-to-increase-awareness-of-skin-health/2458183/CVS Pharmacy, the retail division of CVS Health, is rolling out a new multi-platform Long Live Skin campaign to increase awareness about skin health, sun safety and proper skincare. The Long Live Skin Campaign kicks off today online&nbs
- Study: Smiling May Not Make Us Appear Younger After Allhttps://practicaldermatology.com/news/study-smiling-may-not-make-us-appear-younger-after-all/2458186/Conventional wisdom suggests that smiling makes you appear younger, but researchers at Ben-Gurion University of the Negev in Israel beg to differ. People who smile are actually perceived as older than those with a deadpan or surprised expression, according
- DerMend's New Line Takes On Mature Skin Issueshttps://practicaldermatology.com/news/dermends-new-line-takes-on-mature-skin-issues/2458190/DerMend® is launching DerMend® Mature Skin Solutions. The new product line features DerMend®Fragile Skin Moisturizing Formula, DerMend® Moisturizing Anti-Itch Lotion and DerMend® Moisturizing Bruise Formu
- FDA Accepts Aclaris Therapeutics' NDA for Topical Treatment of Seborrheic Keratosishttps://practicaldermatology.com/news/fda-accepts-aclaris-therapeutics-nda-for-topical-treatment-of-seborrheic-keratosis/2458188/The FDA has accepted Aclaris Therapeutics' New Drug Application (NDA) for A-101 40% topical solution, an investigational drug for the potential treatment of seborrheic keratosis (SK). The NDA acceptance by the FDA in its 74-day letter indicates that the application is sufficiently complete to
- RCM Imaging of Skin Granted Reimbursement Codes by CMS; Wider Adoption Likelyhttps://practicaldermatology.com/news/rcm-imaging-of-skin-granted-reimbursement-codes-by-cms/2458187/After more than two decades of effort, reflectance confocal microscopy (RCM) imaging of skin has been granted reimbursement codes by the US Centers for Medicare and Medicaid Services. A report in Lasers in Sur
- Pfizer Announces U.S. FDA Filing Acceptance of Supplemental New Drug Application for XELJANZ® (tofacitinib citrate) for the Treatment of Adult Patients with Active Psoriatic Arthritishttps://practicaldermatology.com/news/pfizer-announces-us-fda-filing-acceptance-of-supplemental-new-drug-application-for-xeljanz-tofacitinib-citrate-for-the-treatment-of-adult-patients-wit/2458195/(via BusinessWire) Pfizer Inc. announced today that the United States Food and Drug Administration (FDA) has accepted for rev